Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Disease-specific pluripotent stem cells

  • Kang, Hoon-Chul (Department of Pediatrics, Pediatric Epilepsy Clinics, Severance Children's Hospital, Epilepsy Research Institute, Yonsei University College of Medicine)
  • Received : 2010.07.04
  • Accepted : 2010.07.15
  • Published : 2010.08.15
Download PDF
⟨ Previous Next ⟩

Abstract

Induced pluripotent stem (iPS) cells are generated by epigenetic reprogramming of somatic cells through the exogenous expression of transcription factors. Recently, the generation of iPS cells from patients with a variety of genetic diseases was found to likely have a major impact on regenerative medicine, because these cells self-renew indefinitely in culture while retaining the capacity to differentiate into any cell type in the body, thereby enabling disease investigation and drug development. This review focuses on the current state of iPS cell technology and discusses the potential applications of these cells for disease modeling; drug discovery; and eventually, cell replacement therapy.

Keywords

References

  1. Sell S. Stem cells: What are they? Where do they come from? Why are they here? When do they go wrong? Where are they going? In: Sell S, editor, Stem cells handbook. 1st ed. Totowa: Humana Press Co, 2004:1-18.
  2. Kirschstein R. The stem cell. In: Kirschstein R, editor. Stem cells: scientific progress and future research directions. 1st ed. Maryland: National Institutes of Health, 2001:1-4.
  3. Wakayama T, Hayashi Y, Ogura A. Participation of the female pronucleus derived from the second polar body in full embryonic development of mice. J Reprod Fertil 1997;110:263-6. https://doi.org/10.1530/jrf.0.1100263
  4. Hochedlinger K, Jaenisch R. Nuclear reprogramming and pluripotency. Nature 2006; 441:1061-7. https://doi.org/10.1038/nature04955
  5. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76. https://doi.org/10.1016/j.cell.2006.07.024
  6. Maherali N, Hochedlinger K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 2008;3:595-605. https://doi.org/10.1016/j.stem.2008.11.008
  7. Cox JL, Rizzino A. Induced pluripotent stem cells: what lies beyond the paradigm shift. Experimental Biology and Medicine 2010;235:148-58. https://doi.org/10.1258/ebm.2009.009267
  8. Kiskinis E, Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 2010;120:51-9. https://doi.org/10.1172/JCI40553
  9. Eminli S, Foudi A, Stadtfeld M, Maherali N, Ahfeldt T, Mostoslavsky G, et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 2009;41:968-76. https://doi.org/10.1038/ng.428
  10. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008;454:49-55. https://doi.org/10.1038/nature07056
  11. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008;26:795-7. https://doi.org/10.1038/nbt1418
  12. Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, Ding S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 2008;3:568-74. https://doi.org/10.1016/j.stem.2008.10.004
  13. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008;454:49-55. https://doi.org/10.1038/nature07056
  14. Wernig M, Meissner A, Cassady JP, Jaenisch R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008;2:10-2. https://doi.org/10.1016/j.stem.2007.12.001
  15. Blelloch R, Venere M, Yen J, Ramalho-Santos M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 2007;1: 245-7. https://doi.org/10.1016/j.stem.2007.08.008
  16. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009;136:964-77. https://doi.org/10.1016/j.cell.2009.02.013
  17. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008;322:945-9. https://doi.org/10.1126/science.1162494
  18. Gonzalez F, Barragan Monasterio M, Tiscornia G, Montserrat Pulido N, Vassena R, et al. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci 2009;106:8918-22. https://doi.org/10.1073/pnas.0901471106
  19. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009;4:472-6. https://doi.org/10.1016/j.stem.2009.05.005
  20. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324:797-801. https://doi.org/10.1126/science.1172482
  21. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, et al. Disease-specific induced pluripotent stem cells. Cell 2008;134:877-86. https://doi.org/10.1016/j.cell.2008.07.041

Cited by

  1. Residual Undifferentiated Cells During Differentiation of Induced Pluripotent Stem Cells In Vitro and In Vivo vol.21, pp.4, 2010, https://doi.org/10.1089/scd.2011.0131
  2. Prospective In Vitro Models of Channelopathies and Cardiomyopathies vol.2012, pp.None, 2010, https://doi.org/10.1155/2012/439219
  3. Regenerative Medicine for Epilepsy: From Basic Research to Clinical Application vol.14, pp.12, 2010, https://doi.org/10.3390/ijms141223390
  4. Translating regenerative medicine techniques for the treatment of epilepsy vol.3, pp.3, 2010, https://doi.org/10.4103/bc.bc_21_17